Skip to content
Study details
Enrolling now

Patient Controlled Acetaminophen Trial

Yale University
NCT IDNCT06498713ClinicalTrials.gov data as of Apr 2026
Phase

Phase 1

Target enrollment

24

Study length

about 1.1 years

Ages

18+

Locations

1 site in CT

What this study is about

Researchers are testing whether patients can safely use a device to control their own acetaminophen doses. The trial will last for 407 days and involve approximately 24 adults with chronic pain, postoperative pain or other conditions where they experience pain. It aims to see if this method of medication administration is feasible and acceptable.

Simplified from trial records by PatientMatch.

What you may be asked to do

  • 1.Take Acetaminophen 650 mg Oral Tablet
  • 2.Take Acetaminophen 650mg Liquid
  • 3.Use CADD pump

Participation Burden

What's physically and logistically required of participants.

Logistics & Travel
In-person visits

Requires travel to a study site

Physical Intervention
OralOral

How treatment is administered

Treatment Assignment
Randomized (Open Label)

You are randomly assigned, but you will know your treatment.

Extracted study details

Pulled from the trial record to show what is being tested and what the study is measuring.

Drug classes

paracetamol (Reduces fever and pain (mechanism not fully understood)), analgesic (Reduces fever and pain (mechanism not fully understood))

Drug routes

oral (Oral Tablet), oral

Endpoints

Secondary: Mean Pain score

Devices

therapeutic